Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/09/2021 15 8
Capreomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
RBD immunogen Potential treatment - pre-clinical evidence Experimental Vaccine Mar/11/2021 2 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 14
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 13
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/06/2021 8 0
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 10 1
Toremifene Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/28/2020 4 0